The Cancer Genome Atlas project has reported a comprehensive landscape of molecular alterations in bladder cancer, which includes mutations affecting p53 and cohesin in 49% and 11% of the cases, respectively82. This evidence concerns the gene TP53 and urinary bladder cancer.